AKO Capital LLP lifted its position in shares of Monsanto Company (NYSE:MON) by 14.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 248,452 shares of the company’s stock after buying an additional 32,276 shares during the period. Monsanto comprises 2.4% of AKO Capital LLP’s investment portfolio, making the stock its 14th largest position. AKO Capital LLP owned 0.06% of Monsanto worth $29,770,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Monsanto by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the company’s stock valued at $3,636,697,000 after buying an additional 784,418 shares in the last quarter. BlackRock Inc. raised its holdings in shares of Monsanto by 6.5% during the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the company’s stock valued at $3,302,038,000 after buying an additional 1,705,439 shares in the last quarter. State Street Corp raised its holdings in shares of Monsanto by 0.6% during the 2nd quarter. State Street Corp now owns 20,276,780 shares of the company’s stock valued at $2,399,965,000 after buying an additional 122,814 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Monsanto by 3.6% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the company’s stock valued at $1,618,703,000 after buying an additional 499,639 shares in the last quarter. Finally, Northern Trust Corp grew its position in Monsanto by 0.7% during the 2nd quarter. Northern Trust Corp now owns 7,092,929 shares of the company’s stock worth $839,519,000 after acquiring an additional 47,725 shares during the last quarter. 74.41% of the stock is currently owned by institutional investors.
Shares of Monsanto Company (NYSE:MON) traded up C$0.93 during mid-day trading on Friday, hitting C$118.30. The stock had a trading volume of 2,330,000 shares, compared to its average volume of 2,770,809. The company has a market cap of $52,075.66, a price-to-earnings ratio of 21.39, a P/E/G ratio of 1.70 and a beta of 1.05. Monsanto Company has a 12-month low of C$97.35 and a 12-month high of C$122.79. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 4th. The company reported C$0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of C($0.41) by C$0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of C$2.69 billion for the quarter, compared to analyst estimates of C$2.51 billion. During the same period in the previous year, the company posted $0.07 earnings per share. The firm’s revenue was up 4.8% on a year-over-year basis. research analysts forecast that Monsanto Company will post 5.74 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2017/11/12/ako-capital-llp-increases-position-in-monsanto-company-mon.html.
Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target on the stock in a research report on Thursday, September 14th. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. BMO Capital Markets restated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Friday, September 1st. Vetr lowered Monsanto from a “buy” rating to a “hold” rating and set a $122.35 price target on the stock. in a research report on Wednesday, August 2nd. Finally, Jefferies Group LLC restated a “hold” rating and set a $128.00 price target on shares of Monsanto in a research report on Friday, September 15th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of C$124.61.
In related news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of C$120.00, for a total transaction of C$343,200.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Steven Mizell sold 11,526 shares of Monsanto stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of C$119.70, for a total value of C$1,379,662.20. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock worth $5,931,934 over the last 90 days. 0.79% of the stock is currently owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.